DETERMINATION OF A NORMAL LEVEL OF SERUM CA125 IN POSTMENOPAUSAL WOMEN AS A TOOL FOR PREOPERATIVE EVALUATION AND POSTOPERATIVE SURVEILLANCEOF ENDOMETRIAL CARCINOMA
T. Kurihara et al., DETERMINATION OF A NORMAL LEVEL OF SERUM CA125 IN POSTMENOPAUSAL WOMEN AS A TOOL FOR PREOPERATIVE EVALUATION AND POSTOPERATIVE SURVEILLANCEOF ENDOMETRIAL CARCINOMA, Gynecologic oncology (Print), 69(3), 1998, pp. 192-196
In an attempt to determine a normal level of CA125 in postmenopausal w
omen, CA125 levels of normal postmenopausal women (n = 36, 58.2 +/- 8.
1 years) and postmenopausal women undergoing hormone replacement thera
py (HRT) (n = 111, 56.8 +/- 6.1 years) were studied. A mean CA125 conc
entration of 10.0 +/- 3.8 U/ml was found in postmenopausal women witho
ut HRT and was significantly lower than that of postmenopausal women u
ndergoing HRT (12.8 +/- 3.8 U/ml), indicating that the cutoff level of
CA125 in postmenopausal women or women without reproductive organs sh
ould be estimated at a level lower than that conventionally accepted.
A receiver operating characteristic (ROC) curve for a preoperative eva
luation of myometrial invasion was analyzed in postmenopausal women wi
th endometrial cancer (n = 110). A novel cutoff level of 20 U/ml of CA
125 could detect myometrial invasion to more than one-half of the myom
etrium with sensitivity of 69.0%, specificity of 74.1%, positive predi
ctive value of 58.8%, and negative predictive value of 81.6%. In addit
ion, the distribution of CA125 levels was analyzed in patients who had
undergone an operation for endometrial cancer more than 2 years earli
er and as yet had no clinical evidence of recurrence of the disease. N
inety-six point two percent of 619 measurement values were lower than
20 U/ml. These results suggest that the novel CA125 level of 20 U/ml i
s clinically useful for preoperative evaluation and postoperative surv
eillance of endometrial carcinoma. (C) 1998 Academic Press.